Unlock instant, AI-driven research and patent intelligence for your innovation.

Aromatic glucosamine derivative, its preparation method and antitumor application

A tumor and compound technology, applied in the field of medicine, can solve problems such as difficult tumor treatment

Active Publication Date: 2019-07-26
CHIA TAI TIANQING PHARMA GRP CO LTD +2
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, some drugs targeting a certain target will produce obvious drug resistance after being used for a period of time [Bioorganic & Medicinal Chemistry 2012, 20, 3756–3767], which brings difficulties to the later treatment of tumors

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Aromatic glucosamine derivative, its preparation method and antitumor application
  • Aromatic glucosamine derivative, its preparation method and antitumor application
  • Aromatic glucosamine derivative, its preparation method and antitumor application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0050] Embodiment 1: the synthesis of compound II-1

[0051]

[0052] (1) Preparation of 2-chloro-5-nitro-4'-ethoxybenzophenone

[0053] Weigh 2.06g (10mmol) of 2-chloro-5-nitrobenzoic acid and dissolve it in 5mL of thionyl chloride, add 3 drops of pyridine dropwise, then stir and react at 50°C for 3 hours, track by TLC, the reaction of raw materials is complete, stop reaction. The thionyl chloride was removed by rotary evaporation under reduced pressure, and it was directly put into the next reaction without treatment.

[0054] 2.12g (15mmol) of anhydrous AlCl 3 Add to 18mLCH 2 Cl 2 1.35 g (11 mmol) of phenetole was added slowly while keeping the temperature at 0-5° C. After the addition was completed, it was stirred at 0° C. for 15-20 minutes. Then the 2-chloro-5-nitrobenzoyl chloride prepared in the previous step was dissolved in 6mL CH 2 Cl 2 Add it to the phenetole system at a rate that keeps the temperature at 0-5°C, and react for 12 hours to obtain a black-gre...

Embodiment 2

[0061] Embodiment 2: the synthesis of compound II-2

[0062]

[0063] (1) Preparation of compound 3

[0064] Weigh 2.06g (10mmol) of 2-chloro-5-nitrobenzoic acid and dissolve it in 5mL of thionyl chloride, add 3 drops of pyridine dropwise, then stir and react at 50°C for 3 hours, track by TLC, the reaction of raw materials is complete, stop reaction. The thionyl chloride was removed by rotary evaporation under reduced pressure, and it was directly put into the next reaction without treatment.

[0065] 2.12g (15mmol) of anhydrous AlCl 3 Add to 18mLCH 2 Cl 2 1.35 g (11 mmol) of phenetole was added slowly while keeping the temperature at 0-5° C. After the addition was completed, it was stirred at 0° C. for 15-20 minutes. Then the 2-chloro-5-nitrobenzoyl chloride prepared in the previous step was dissolved in 6mL CH 2 Cl 2 Add it to the phenetole system at a rate that keeps the temperature at 0-5°C, and react for 12 hours to obtain a black-green solution. According to T...

Embodiment 3

[0072] Embodiment 3: the synthesis of compound II-3

[0073]

[0074] (1) Preparation of compound 6

[0075] Weigh 4.52g (25mmol) of 2-methyl-5-nitrobenzoic acid and dissolve it in 8mL of thionyl chloride, add 3 drops of pyridine dropwise, then stir and react at 50°C for 3h, track by TLC, the reaction of raw materials is complete, stop reaction. The thionyl chloride was removed by rotary evaporation under reduced pressure, and it was directly put into the next reaction without treatment.

[0076] Anhydrous AlCl 3 5.00g (37.5mmol) was added to 45mLCH 2 Cl 2 3.36 g (27.5 mmol) of phenetole was added slowly while keeping the temperature at 0-5° C. After the addition was completed, it was stirred at 0° C. for 15-20 minutes. Then the 2-methyl-5-nitrobenzoyl chloride prepared in the previous step was dissolved in 14mL CH 2 Cl 2 Add it to the phenetole system at a rate that keeps the temperature at 0-5°C, and react for 1 hour to obtain a black-green solution. According to ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the field of medicinal chemistry, and particularly relates to a diarylamino glucosan derivative, and a preparation method and an anti-tumor purpose thereof, wherein the diarylamino glucosan derivative particularly relates to a compound shown as a formula I. The invention also relates to the preparation method of the diarylamino glucosan derivative, and the purpose of the diarylamino glucosan derivative in an aspect of preparing medicine for treating tumor diseases. The diarylamino glucosan derivative particularly has the obvious inhibition effects on human skin quamous cell carcinoma cells, human lung carcinoma cells and human colon cancer cells.

Description

technical field [0001] The invention belongs to the field of medicine, and specifically relates to a 1,2-O-isopropylidene-5-arylamino-α-glucofuranose derivative, its preparation method, and its use in the preparation of medicines for treating tumor diseases . Background technique [0002] The treatment of cancer has long been a worldwide problem. The essence of cell carcinogenesis may be the unlimited proliferation of cells caused by the disorder of cell signal transduction pathways. Therefore, using some key enzymes of cell signal transduction pathways related to tumor cell differentiation and proliferation as drug targets to discover new anticancer drugs with high efficiency and low toxicity has become an important direction for the development of anticancer drugs today. For example, gefitinib [AstraZeneca, London, U.K., http: / / www.astrazeneca.com / ], erlotinib [Roche, Ltd, Basel, Switzerland, http: / / www.roche.com / ], lapatinib [WO 99 / 35146], etc. have been successfully u...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07H15/04C07H1/00A61K31/7048A61P35/00
Inventor 李宝林孙宝丽王丽丽张喜全顾红梅张娅玲
Owner CHIA TAI TIANQING PHARMA GRP CO LTD